Jaafar N. Haidar

Dragonfly Therapeutics (United States)

Medicine · Health Sciences

12h-index5.7kcitations54works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(31), Monoclonal and Polyclonal Antibodies Research(26), Immunotherapy and Immune Responses(18), Immune Cell Function and Interaction(14), CAR-T cell therapy research(10)

Publications53 total

962 A novel alpha-active IL-2-Fc has expanded therapeutic index and robust monotherapy efficacy in mouse cancer models and strong synergy with PD-1 blockade
Regular and Young Investigator Award Abstracts·2024Open Access
Data from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Supplementary Data File from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Data from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Supplementary Data File from Bispecific Targeting of PD-1 and PD-L1 Enhances T-cell Activation and Antitumor Immunity
2023Open Access
Supplementary Tables S1-S4 and Supplementary Figures S1-S6 from Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance
2023Open Access
Figure S8 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S6 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S3 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S9 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Supplementary Materials and Methods from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Table S1 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Supplementary Materials and Methods from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S1 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S4 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Data from Molecular Basis for Necitumumab Inhibition of EGFR Variants Associated with Acquired Cetuximab Resistance
2023Open Access
Table S1 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S3 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S7 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
Figure S8 from Characterization of 7A5: A Human CD137 (4-1BB) Receptor Binding Monoclonal Antibody with Differential Agonist Properties That Promotes Antitumor Immunity
2023Open Access
page 1 of 3Next →

Frequent Co-authors

Ruslan D. Novosiadly(37), Dale L. Ludwig(36), Michael Kalos(35), Carmine Carpenito(33), Ivan Inigo(33), David Surguladze(33), Anthony L. Pennello(33), Darin Chin(33), Andreas Sonyi(33), Gregory D. Plowman(32), Xinlei Chen(32), Amélie Forest(32), Michael J. Topper(31), Helen Kotanides(30), Leyi Shen(30), Douglas Burtrum(28), Rose Marie Sattler(25), Maria B. Lebron(25), Juqun Shen(25), Jingxing Li(25)